On June 13, 2026 Principal, Ms. Pauli Wongspoke at the “Entrepreneurial Workshop,” an elective course under the Master of Technology Entrepreneurship program at the Hong Kong Polytechnic University (PolyU).

Invited as the course's external expert, Pauli shared her extensive expertise with an audience of approximately 35 aspiring tech entrepreneurs, primarily from mainland China.

The interactive session focused on the highly relevant topic “如何运用专利构建科技企业的护城河” (How to Use Patents to Build a Moat for Tech Enterprises).” Drawing from her deep background in patent drafting and global prosecution, Pauli provided real-world case studies, strategic advice, and practical insights on how startups can effectively leverage intellectual property as a defensive moat to protect their tech innovations and scale their businesses safely.

我们的过去活动

Recommended Insights

RNAi Patent Success in China: Overcoming “Comprising” Claim Challenges

2025年3月10日
An Update on Sufficiency and Inventiveness of RNAi Patents in China RNAi is a fast-developing technology that has gained traction in the pharmaceutical industry as a promising therapeutic agent. It is important to follow closely RNAi patent proceedings to learn how different examination boards and courts understand and handle these new technologies. The first-ever invalidation […]

China Patent Office (CNIPA) Releases More Details About Patent Term Adjustment (PTA) in the Draft Examination Guidelines

2021年10月19日
The new 4th Amendment of the Chinese Patent Law came into effect on June 1, 2021. Right before that date, the Chinese Patent Office (“CNIPA”) released some “Interim Measures” to give us a taste of what was to come, though they have yet to released the actual Implementation Rules. Two months later, CNIPA finally released […]

Updates on Hong Kong Patents Examination Guidelines in 2024

2024年2月29日
The Intellectual Property Department of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China (HKIPD) has recently made several updates to the Hong Kong Patents Examination Guidelines, effective from 26 January, 2024. These changes mainly clarify and reflect the Registry’s current practices regarding patent examination for Standard Patent (R) […]

Do Promotional Marketing Materials Constitute an “Offer for Sale” under Chinese Patent Law? Bayer IP GmbH v. Nanjing Hang Seng Pharmaceutical

2023年12月12日
Bayer's blockbuster drug Rivaroxaban has seen its share of patent litigations in China, several of which are big enough to be listed as Top 10 IP cases or 50 Representative IP cases. We summarized an invalidation case back in 2020 where all of Bayer’s claims directed towards the compound were upheld. Recently, another Rivaroxaban case […]
Top crossarrow-right